• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立具有R471X突变的X连锁Alport综合征模型小鼠。

Establishment of X-linked Alport syndrome model mice with a R471X mutation.

作者信息

Hashikami Kentarou, Asahina Makoto, Nozu Kandai, Iijima Kazumoto, Nagata Michio, Takeyama Michiyasu

机构信息

Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi, Fujisawa, Kanagawa, 251-8555, Japan.

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Hyogo 651-0017, Japan.

出版信息

Biochem Biophys Rep. 2018 Dec 12;17:81-86. doi: 10.1016/j.bbrep.2018.12.003. eCollection 2019 Mar.

DOI:10.1016/j.bbrep.2018.12.003
PMID:30582011
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6295608/
Abstract

Alport syndrome (AS) is an inherited disorder characterized by glomerular basement membrane (GBM) abnormality and development of chronic kidney disease at an early age. The cause of AS is a genetic mutation in type IV collagen, and more than 80% of patients have X-linked AS (XLAS) with mutation in . Although the causal gene has been identified, mechanisms of progression have not been elucidated, and no effective treatment has been developed. In this study, we generated a mutant mouse harboring a nonsense mutation (R471X) obtained from a patient with XLAS using clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated system. mRNA and protein expressions were not observed in the kidneys of hemizygous R471X male mice. R471X mice showed proteinuria and hematuria. Pathology revealed progression of glomerulosclerosis and interstitial fibrosis by age. Electron microscopy identified irregular thickening in GBM accompanied by irregular lamination. These observations were consistent with the clinical and pathological features of patients with AS and other established models. In addition, our mice models develop end-stage renal disease at the median age of 28 weeks, much later compared to previous models much more consistent with clinical course of human XLAS. Our models have advantages for future experiments in regard with treatment for human XLAS.

摘要

阿尔波特综合征(AS)是一种遗传性疾病,其特征为肾小球基底膜(GBM)异常以及早年出现慢性肾脏病。AS的病因是IV型胶原基因突变,超过80%的患者患有X连锁AS(XLAS),其 发生突变。尽管致病基因已被确定,但疾病进展机制尚未阐明,也未开发出有效的治疗方法。在本研究中,我们使用成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关系统,构建了一只携带从一名XLAS患者获得的无义突变(R471X)的突变小鼠。在半合子R471X雄性小鼠的肾脏中未观察到 mRNA和蛋白表达。R471X小鼠出现蛋白尿和血尿。病理学检查显示,随着年龄增长,肾小球硬化和间质纤维化逐渐进展。电子显微镜检查发现GBM不规则增厚并伴有不规则分层。这些观察结果与AS患者及其他已建立模型的临床和病理特征一致。此外,我们的小鼠模型在28周龄的中位年龄时发展为终末期肾病,与先前模型相比要晚得多,这与人类XLAS的临床病程更为一致。我们的模型在未来针对人类XLAS治疗的实验方面具有优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec1/6295608/c3a77946b229/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec1/6295608/1230538acae3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec1/6295608/fde71211f4e4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec1/6295608/f4341283a0ad/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec1/6295608/c3a77946b229/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec1/6295608/1230538acae3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec1/6295608/fde71211f4e4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec1/6295608/f4341283a0ad/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dec1/6295608/c3a77946b229/gr4.jpg

相似文献

1
Establishment of X-linked Alport syndrome model mice with a R471X mutation.建立具有R471X突变的X连锁Alport综合征模型小鼠。
Biochem Biophys Rep. 2018 Dec 12;17:81-86. doi: 10.1016/j.bbrep.2018.12.003. eCollection 2019 Mar.
2
A mouse model for X-linked Alport syndrome induced by Del-ATGG in the gene.一种由基因中Del-ATGG诱导的X连锁Alport综合征小鼠模型。
Front Med (Lausanne). 2023 Mar 8;10:1086756. doi: 10.3389/fmed.2023.1086756. eCollection 2023.
3
X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.X连锁遗传性奥尔波特综合征犬模型显示,肾小球系膜丝状伪足侵入毛细血管襻是肾小球损伤的早期事件。
PLoS One. 2016 Dec 13;11(12):e0168343. doi: 10.1371/journal.pone.0168343. eCollection 2016.
4
Bidirectional, non-necrotizing glomerular crescents are the critical pathology in X-linked Alport syndrome mouse model harboring nonsense mutation of human COL4A5.双向、非坏死性肾小球新月体是携带有人类 COL4A5 无义突变的 X 连锁 Alport 综合征小鼠模型中的关键病理学改变。
Sci Rep. 2020 Nov 3;10(1):18891. doi: 10.1038/s41598-020-76068-4.
5
Correlation between mRNA expression level of the mutant COL4A5 gene and phenotypes of XLAS females.突变型COL4A5基因的mRNA表达水平与X连锁遗传性Alport综合征女性患者表型之间的相关性
Exp Biol Med (Maywood). 2007 May;232(5):638-42.
6
Alport syndrome. Molecular genetic aspects.奥尔波特综合征。分子遗传学方面。
Dan Med Bull. 2009 Aug;56(3):105-52.
7
A Novel Deep Learning Approach for Analyzing Glomerular Basement Membrane Lesions in a Mouse Model of X-Linked Alport Syndrome.
Am J Pathol. 2025 Jan;195(1):143-154. doi: 10.1016/j.ajpath.2024.10.004. Epub 2024 Oct 18.
8
Aberrant Splicing of Intronic Variant Contribute to the Pathogenesis of X-Linked Alport Syndrome: A Case Series.内含子变异的异常剪接导致X连锁Alport综合征的发病机制:病例系列
Int J Nephrol Renovasc Dis. 2024 Jun 4;17:167-174. doi: 10.2147/IJNRD.S459363. eCollection 2024.
9
X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.与同义p.Gly292Gly突变相关的X连锁Alport综合征改变了IV型胶原α5链基因的剪接受体位点。
Clin Exp Nephrol. 2016 Oct;20(5):699-702. doi: 10.1007/s10157-015-1197-9. Epub 2015 Nov 18.
10
Mouse model of X-linked Alport syndrome.X连锁遗传性肾炎的小鼠模型。
J Am Soc Nephrol. 2004 Jun;15(6):1466-74. doi: 10.1097/01.asn.0000130562.90255.8f.

引用本文的文献

1
A novel mouse model for X-linked Alport syndrome induced by splicing mutation in the Col4a5 gene.一种由Col4a5基因剪接突变诱导的X连锁Alport综合征新型小鼠模型。
Sci Rep. 2025 May 18;15(1):17236. doi: 10.1038/s41598-025-01663-2.
2
iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome.iPSC 衍生的表达 IV 型胶原 α5 的肾类器官模型模拟 Alport 综合征。
Commun Biol. 2023 Sep 28;6(1):854. doi: 10.1038/s42003-023-05203-4.
3
Alport Syndrome: Clinical Spectrum and Therapeutic Advances.奥尔波特综合征:临床谱与治疗进展

本文引用的文献

1
Natural History and Genotype-Phenotype Correlation in Female X-Linked Alport Syndrome.女性X连锁遗传性肾炎的自然病史及基因型-表型相关性
Kidney Int Rep. 2017 May 4;2(5):850-855. doi: 10.1016/j.ekir.2017.04.011. eCollection 2017 Sep.
2
X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.X连锁和常染色体隐性遗传性奥尔波特综合征:致病变异特征及进一步的基因型-表型相关性
PLoS One. 2016 Sep 14;11(9):e0161802. doi: 10.1371/journal.pone.0161802. eCollection 2016.
3
X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
Kidney Med. 2023 Mar 21;5(5):100631. doi: 10.1016/j.xkme.2023.100631. eCollection 2023 May.
4
A mouse model for X-linked Alport syndrome induced by Del-ATGG in the gene.一种由基因中Del-ATGG诱导的X连锁Alport综合征小鼠模型。
Front Med (Lausanne). 2023 Mar 8;10:1086756. doi: 10.3389/fmed.2023.1086756. eCollection 2023.
5
Identification of variants in Chinese patients with familial hematuria.中国家族性血尿患者变异的鉴定。
Front Genet. 2023 Jan 9;13:1064491. doi: 10.3389/fgene.2022.1064491. eCollection 2022.
6
A Comparative Presentation of Mouse Models That Recapitulate Most Features of Alport Syndrome.重现 Alport 综合征大部分特征的小鼠模型的比较介绍。
Genes (Basel). 2022 Oct 18;13(10):1893. doi: 10.3390/genes13101893.
7
Genetic Kidney Diseases (GKDs) Modeling Using Genome Editing Technologies.利用基因组编辑技术建立遗传性肾脏疾病模型。
Cells. 2022 May 6;11(9):1571. doi: 10.3390/cells11091571.
8
NanoLuc reporters identify nonsense mutations susceptible to drug-induced stop codon readthrough.纳米荧光素酶报告基因可识别对药物诱导的终止密码子通读敏感的无义突变。
iScience. 2022 Feb 8;25(3):103891. doi: 10.1016/j.isci.2022.103891. eCollection 2022 Mar 18.
9
Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Alport Syndrome: A Primer for Clinicians.《Alport 综合征的分子基础、诊断挑战与治疗方法:临床医师指南》
Int J Mol Sci. 2021 Oct 14;22(20):11063. doi: 10.3390/ijms222011063.
10
Creation of X-linked Alport syndrome rat model with Col4a5 deficiency.建立 X 连锁 Alport 综合征大鼠模型 Col4a5 缺陷
Sci Rep. 2021 Oct 21;11(1):20836. doi: 10.1038/s41598-021-00354-y.
与同义p.Gly292Gly突变相关的X连锁Alport综合征改变了IV型胶原α5链基因的剪接受体位点。
Clin Exp Nephrol. 2016 Oct;20(5):699-702. doi: 10.1007/s10157-015-1197-9. Epub 2015 Nov 18.
4
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.通过 CRISPR/Cas 介导的基因组工程一步生成携带多个基因突变的小鼠。
Cell. 2013 May 9;153(4):910-8. doi: 10.1016/j.cell.2013.04.025. Epub 2013 May 2.
5
Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.通过Cas9/RNA介导的基因靶向技术生成基因编辑小鼠。
Cell Res. 2013 May;23(5):720-3. doi: 10.1038/cr.2013.46. Epub 2013 Apr 2.
6
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.临床实践中治疗 Alport 综合征的建议:Alport 综合征研究协作组的声明。
Pediatr Nephrol. 2013 Jan;28(1):5-11. doi: 10.1007/s00467-012-2138-4. Epub 2012 Mar 30.
7
HEREDITARY FAMILIAL CONGENITAL HAEMORRHAGIC NEPHRITIS.遗传性家族性先天性出血性肾炎
Br Med J. 1927 Mar 19;1(3454):504-6. doi: 10.1136/bmj.1.3454.504.
8
Genotype-phenotype correlation in X-linked Alport syndrome.X 连锁型 Alport 综合征的基因型-表型相关性。
J Am Soc Nephrol. 2010 May;21(5):876-83. doi: 10.1681/ASN.2009070784. Epub 2010 Apr 8.
9
Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis.选择一种小鼠模型来研究Alport肾小球肾炎的分子病理生物学。
Kidney Int. 2007 Apr;71(7):615-8. doi: 10.1038/sj.ki.5002115. Epub 2007 Feb 7.
10
Mouse model of X-linked Alport syndrome.X连锁遗传性肾炎的小鼠模型。
J Am Soc Nephrol. 2004 Jun;15(6):1466-74. doi: 10.1097/01.asn.0000130562.90255.8f.